BIOMAT Database Logo BIOMAT Database Logo

Diabetogenic action of somatostatin in healthy subjects: effect of amino acids and somatostatin upon blood glucose, serum insulin, and glucagon. 1978

W K Waldhäusl, and P Bratusch-Marrain, and B Loebenstein

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D013004 Somatostatin A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal. Cyclic Somatostatin,Somatostatin-14,Somatotropin Release-Inhibiting Hormone,SRIH-14,Somatofalk,Somatostatin, Cyclic,Somatotropin Release-Inhibiting Factor,Stilamin,Somatostatin 14,Somatotropin Release Inhibiting Factor,Somatotropin Release Inhibiting Hormone

Related Publications

W K Waldhäusl, and P Bratusch-Marrain, and B Loebenstein
Effect of a 12-hour subcutaneous infusion of somatostatin-14 on blood glucose, insulin and glucagon levels in healthy subjects and insulin dependent diabetics.
January 1986, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
W K Waldhäusl, and P Bratusch-Marrain, and B Loebenstein
Diurnal variation in blood sugar and serum insulin in response to glucose and/or glucagon in healthy subjects.
March 1976, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
W K Waldhäusl, and P Bratusch-Marrain, and B Loebenstein
Effect of intranasal glucagon on blood glucose levels in healthy subjects and hypoglycaemic patients with insulin-dependent diabetes.
June 1988, Lancet (London, England),
W K Waldhäusl, and P Bratusch-Marrain, and B Loebenstein
Synergistic effect of essential amino acids and glucose upon insulin secretion in man.
February 1970, Diabetes,
W K Waldhäusl, and P Bratusch-Marrain, and B Loebenstein
Effect of glucagon on serum insulin, plasma glucose and free fatty acids in man.
February 1966, Metabolism: clinical and experimental,
W K Waldhäusl, and P Bratusch-Marrain, and B Loebenstein
Effect of somatostatin on blood glucose, plasma growth hormone, insulin, and free fatty acids in normal subjects and acromegalic patients.
November 1974, Metabolism: clinical and experimental,
W K Waldhäusl, and P Bratusch-Marrain, and B Loebenstein
The effect of glucose anomers upon insulin and glucagon secretion.
December 1974, Diabetologia,
W K Waldhäusl, and P Bratusch-Marrain, and B Loebenstein
[Free amino acids in the blood serum of healthy subjects and patients with arteriosclerosis].
January 1975, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
W K Waldhäusl, and P Bratusch-Marrain, and B Loebenstein
Effect of verapamil on glucose response to intravenous injection of glucagon and insulin in healthy subjects.
July 1980, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
W K Waldhäusl, and P Bratusch-Marrain, and B Loebenstein
Serum magnesium in insulin-dependent diabetics and healthy subjects in relation to insulin secretion and glycemia during glucose-glucagon test.
February 1985, Experimental and clinical endocrinology,
Copied contents to your clipboard!